Literature DB >> 1163545

Defects of taste and smell in patients with hypothyroidism.

R J McConnell, C E Menendez, F R Smith, R I Henkin, R S Rivlin.   

Abstract

Taste and smell functions were measured in 18 unselected patients with untreated primary hypothyroidism, and in 15 of the 18 patients after treatment with thyroid hormones. Before treatment, 9 of the 18 patients (50 per cent) were aware of some alteration in their sense of taste, and 7 of the 18 patients (39 per cent) were aware of some alteration in their sense of smell. Distoritions of tase (dysgeusia) and smell (dysosmia) were frequent complaints among the untreated patients; dysgeusia was observed by 7 patients (39 per cent) and dysosmia by 3 patients (17 per cent). Median detection and recognition thresholds for four taste stimuli salt (sodium chloride), sweet (sucrose), sour (hydrochloric acid) and bitter (urea), and for two smell stimuli (pyridine and nitrobenzene), were determined in each patient before and after treatment with thyroid hormones. Before treatment, decreased taste acuity (hypogeusia) for at least one stimulus was observed in 14 of the patients (83 per cent); the most common abnormalities were in the detection and recognition of bitter stimuli. Median detection thresholds for both smell stimuli were also markedly elevated (hyposmia) before therapy. Treatment with throid hormones largely reversed both the taste and smell defects. In one patient, taste and smell abnormalities were completely corrected after 16 days of treatment with thyroxine. This study indicates that taste and smell defects are common clinical abnormalities in primary hypothyroidism, and suggests that these defects may contribute to the anorexia and lack of interest in eating which are frequently observed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1163545     DOI: 10.1016/0002-9343(75)90394-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Drug-target based cross-sectional analysis of olfactory drug effects.

Authors:  Jörn Lötsch; Helena Daiker; Antje Hähner; Alfred Ultsch; Thomas Hummel
Journal:  Eur J Clin Pharmacol       Date:  2015-02-11       Impact factor: 2.953

2.  Abnormalities of taste.

Authors: 
Journal:  Br Med J       Date:  1976-07-24

Review 3.  Smell and autoimmunity: a comprehensive review.

Authors:  Carlo Perricone; Netta Shoenfeld; Nancy Agmon-Levin; Caterina de Carolis; Roberto Perricone; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 4.  Making sense with thyroid hormone--the role of T(3) in auditory development.

Authors:  Lily Ng; Matthew W Kelley; Douglas Forrest
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

5.  Olfactory reflexes in newborn infants.

Authors:  G Gauthaman; L Jayachandran; K Prabhakar
Journal:  Indian J Pediatr       Date:  1984 Jul-Aug       Impact factor: 1.967

6.  Human salivary gustin is a potent activator of calmodulin-dependent brain phosphodiesterase.

Authors:  J S Law; N Nelson; K Watanabe; R I Henkin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 7.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

Review 8.  [Olfactory dysfunction. Epidemiology, pathophsiological classification, diagnosis and therapy].

Authors:  G Förster; M Damm; H Gudziol; T Hummel; K-B Hüttenbrink; T Just; A Muttray; H Seeber; A Temmel; A Welge-Lüssen
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

9.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

Review 10.  Drug-induced taste disorders.

Authors:  Richard L Doty; Muhammad Shah; Steven M Bromley
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.